Real-world evidence from a European cohort study of patients with treatment resistant depression: Healthcare resource utilization.

Data de publicació: Data Ahead of Print:

Autors de IIS La Fe

Autors aliens a IIS La Fe

  • Heerlein, K.
  • De Giorgi, S.
  • Degraeve, G.
  • Frodl, T.
  • Hagedoorn, W.
  • Oliveira-Maia, A. J.
  • Otte, C.
  • Perez Sola, V
  • Rathod, S.
  • Rosso, G.
  • Vita, A.
  • Morrens, J.
  • Rive, B.
  • Mulhern Haughey S
  • Kambarov, Y.
  • Young, A. H.

Grups d'Investigació

Abstract

Treatment resistant depression (TRD) is diagnosed when patients experiencing a major depressive episode fail to respond to =2 treatments. Along with substantial indirect costs, patients with TRD have higher healthcare resource utilization (HCRU) than other patients with depression. However, research on the economic impact of this HCRU, and differences according to response to treatment, is lacking.

Copyright © 2021 The Authors. Published by Elsevier B.V. All rights reserved.

Dades de la publicació

ISSN/ISSNe:
0165-0327, 1573-2517

JOURNAL OF AFFECTIVE DISORDERS  ELSEVIER SCIENCE BV

Tipus:
Article
Pàgines:
442-450
PubMed:
34742998
Factor d'Impacte:
1,791 SCImago
Quartil:
Q1 SCImago

Cites Rebudes en Web of Science: 15

Documents

  • No hi ha documents

Mètriques

Filiacions mostrar / ocultar

Keywords

  • Healthcare resource utilization, Major depressive disorder, Observational study, Real-world evidence, Treatment resistant depression

Compartir la publicació